机器人辅助腹腔镜前列腺切除术当日出院趋势与安全性:国家癌症数据库大流行前后时期比较
基于国家癌症数据库,比较大流行前(2018—2019年)与大流行期(2020年)机器人辅助腹腔镜前列腺切除术当日出院的使用情况,并评估其对死亡与再入院的影响。111117名男性中8997例(8%)接受当日出院;大流行期当日出院几率高于大流行前(aOR 1.37;95%CI 1.31-1.45;P<.001)。经逆概率治疗加权调整后,当日出院与非当日出院的30天死亡、90天死亡及30天再入院无差异。
要点
- 大流行期机器人辅助腹腔镜前列腺切除术当日出院几率较大流行前升高(aOR 1.37;95%CI 1.31-1.45;P<.001)。
- 合并症多、非私人保险及高危前列腺癌患者当日出院率较低(P<.001)。
- 学术机构及机器人辅助腹腔镜前列腺切除术量最高四分位医院当日出院率较高(P<.001)。
核心结论
- 大流行后机器人辅助腹腔镜前列腺切除术当日出院稳步增加;确定标准化当日出院所需因素与资源对其未来广泛开展至关重要。
研究设计与样本
- 基于国家癌症数据库的回顾性分析,纳入大流行前(2018—2019年)与大流行期(2020年)接受机器人辅助腹腔镜前列腺切除术的男性,共111117人,其中8997例(8%)接受当日出院。
- 采用多变量逻辑回归评估大流行期较大流行前当日出院的几率,并使用逆概率治疗加权评估当日出院对30天死亡、90天死亡和30天再入院的影响。
主要发现
- 111117名男性中8997例(8%)接受当日出院。
- 合并症较多、非私人保险及高危前列腺癌患者当日出院率较低(P<.001)。
- 学术机构及机器人辅助腹腔镜前列腺切除术量最高四分位医院当日出院率较高(P<.001)。
- 大流行期接受机器人辅助腹腔镜前列腺切除术者较大流行前当日出院几率升高(aOR 1.37;95%CI 1.31-1.45;P<.001)。
- 逆概率治疗加权调整后,当日出院与非当日出院的30天死亡(aOR 0.98;95%CI 0.47-2.01;P=.95)、90天死亡(aOR 1.09;95%CI 0.60-1.97;P=.76)及30天再入院(aOR 0.90;95%CI 0.76-1.06;P=.21)均无差异。
关键数值与推荐
- 大流行期较大流行前当日出院几率:aOR 1.37;95%CI 1.31-1.45;P<.001。
- 当日出院与非当日出院30天死亡:aOR 0.98;95%CI 0.47-2.01;P=.95。
- 当日出院与非当日出院90天死亡:aOR 1.09;95%CI 0.60-1.97;P=.76。
- 当日出院与非当日出院30天再入院:aOR 0.90;95%CI 0.76-1.06;P=.21。
临床怎么用
- 作者认为,确定标准化机器人辅助腹腔镜前列腺切除术当日出院所需因素与资源,对其未来广泛开展至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess and compare the use of same-day discharge (SDD) for robot-assisted laparoscopic prostatectomy (RALP) between the "Pre-pandemic" and "Pandemic" periods and investigate SDD impact on mortality and readmissions. MATERIALS AND METHODS: We examined data from the National Cancer Database on men receiving RALP in the "Pre-pandemic" (2018-2019) and "Pandemic" (2020) periods. We analyzed the differences in patient and hospital characteristics between SDD and non-SDD patients. Multivariable logistic regression analysis was performed to evaluate the likelihood of SDD during "Pandemic" versus "Pre-pandemic" periods. Inverse probability treatment weighting (IPTW) was utilized to assess the impact of SDD on 30-day mortality, 90-day mortality, and 30-day readmissions, adjusting for patient and hospital characteristics. RESULTS: Out of 111,117 men, 8997 (8%) received SDD. Patients with more comorbidities, non-private insurance, and high-risk prostate cancer reported lower SDD rates (P <.001). Higher SDD rates were observed at academic facilities and those in the top RALP volume quartile (P <.001). Patients who underwent RALP during the "Pandemic" period had increased odds of SDD compared to those receiving RALP in the "Pre-pandemic" period (aOR 1.37; 95%CI 1.31-1.45; P <.001). When comparing SDD and non-SDD patient outcomes, after IPTW adjustment, there was no difference in the odds of 30-day mortality (aOR 0.98; 95%CI 0.47-2.01; P = .95), 90-day mortality (aOR 1.09; 95%CI 0.60-1.97; P = .76), or 30-day readmissions (aOR 0.90; 95%CI 0.76-1.06, P = .21). CONCLUSION: SDD for RALP increased steadily after pandemic. Identifying factors and necessary resources to standardize SDD for RALP will be crucial for its widespread adoption in the coming years.
引用
- Dagnino F, Labban M, Berk B, et al. Trends and Safety of Same-day Discharge for Robot-assisted Laparoscopic Prostatectomy: A Comparison Between the Pre-pandemic and Pandemic Periods From the National Cancer Database. Urology. 2024. PMID: 39447881. doi:10.1016/j.urology.2024.10.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。